In today’s ACT Brief, we examine how large de-identified datasets are reshaping trial design and site strategy, why global ...

The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.

Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

As clinical research evolves at an unprecedented pace, it’s important that physicians understand how emerging trends may ...

Explore the unique mechanisms of bispecific antibodies and their rapid availability compared to CAR T-cell therapies in cancer treatment.

By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...

In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the ...

Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...

SHANGHAI, May 23, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at ...

The new approach brings research directly to participants using decentralised and patient-centric digital engagement tools.

This article is part of our series on clinical data considerations. Read How to Prepare for Disclosure. For publicly traded biotech companies, disclosing clinical trial data can be an exciting ...